Evidence map›Paper›PMID 34361181›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Hydrotalcite-Embedded Magnetite Nanoparticles for Hyperthermia-Triggered Chemotherapy.

Konstantinos Simeonidis, Efthimia Kaprara, Pilar Rivera-Gil, Ruixue Xu, Francisco J Teran, Evgenios Kokkinos, Athanassios Mitropoulos, Nikolaos Maniotis, Lluis Balcells

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Konstantinos SimeonidisDepartment of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-9804-4690
Efthimia KapraraDepartment of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-4849-1091
Pilar Rivera-GilIntegrative Biomedical Materials and Nanomedicine Lab, Universitat Pompeu Fabra, 08003 Barcelona, Spain.ORCID 0000-0002-6587-7538
Ruixue XuIntegrative Biomedical Materials and Nanomedicine Lab, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Francisco J TeranIMDEA-Nanociencia, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
Evgenios KokkinosEcoresources P.C., Giannitson-Santaroza Str. 15-17, 54627 Thessaloniki, Greece.
Athanassios MitropoulosHephaestus Advanced Laboratory, Department of Chemistry, International Hellenic University, 65404 Kavala, Greece.
Nikolaos ManiotisDepartment of Physics, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0003-1825-9961
Lluis BalcellsInstitut de Ciencia de Materials de Barcelona, CSIC, 08193 Bellaterra, Spain.
Aristotle University of Thessaloniki · GRUniversitat Pompeu Fabra · ESIMDEA Nanoscience · ESInstitut de Ciència de Materials de Barcelona · ESInternational Hellenic University · GR

Funding

Comunidad de Madrid NANOMAGCOSTCOST Actions CA17115 (MyWave)COST Actions CA17140 (Nano2Clinic)European Commission 654360Ministerio de Ciencia e Innovación MAT2017-85617-RMinisterio de Ciencia e Innovación RED2018-102626-TMinisterio de Ciencia e Innovación SEV-2016-0686Ministry of Science, Innovation and Universities 2017 SGR 1054Ministry of Science, Innovation and Universities AEI-SAF2015-73052-EXPMinistry of Science, Innovation and Universities CTQ2013-45433-PFEDERMinistry of Science, Innovation and Universities MAT2016-75362-C3-2-RMinistry of Science, Innovation and Universities MDM-2014-0370-04Ministry of Science, Innovation and Universities RYC-2012-10059Stavros Niarchos Foundation Eastern Macedonia and Thrace Institute of Technology fellowships
6 · The paper itself

Abstract

A magnetic nanocomposite, consisting of Fe

Indexed as

cell internalizationcontinuous flow synthesisdrug deliveryFe3O4layered double hydroxidemagnetic hyperthermiananocomposite

Identifiers

PMID34361181
PMCPMC8308439
OpenAlexW3182265909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.